Ditchcarbon
  • Contact
  1. Organizations
  2. Diasorin
Public Profile
Pharmaceutical Preparation Manufacturing
IT
updated 4 days ago

Diasorin

Company website

DiaSorin S.p.A., headquartered in Italy, is a prominent player in the global diagnostics industry, specialising in the development and production of innovative diagnostic solutions. Founded in 1968, the company has established a strong presence in major operational regions, including Europe, North America, and Asia. With a focus on immunodiagnostics and molecular diagnostics, DiaSorin offers a range of unique products, including its LIAISON® and Simplexa™ platforms, which are renowned for their accuracy and efficiency. The company has achieved significant milestones, such as expanding its product portfolio and enhancing its technological capabilities, solidifying its market position as a leader in the field. Recognised for its commitment to quality and innovation, DiaSorin continues to advance healthcare diagnostics, making a meaningful impact on patient care worldwide.

DitchCarbon Score

How does Diasorin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

52

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Diasorin's score of 52 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

69%

Let us know if this data was useful to you

Diasorin's reported carbon emissions

In 2024, DiaSorin reported total carbon emissions of approximately 243,315,000 kg CO2e globally, with emissions distributed across various scopes: 3,513,000 kg CO2e (Scope 1), 13,546,000 kg CO2e (Scope 2), and a significant 226,256,000 kg CO2e (Scope 3). In the UK, emissions totalled about 248,000 kg CO2e, comprising 80,000 kg CO2e (Scope 1), 16,000 kg CO2e (Scope 2), and 151,000 kg CO2e (Scope 3). DiaSorin has set ambitious climate commitments, aiming for Net Zero emissions by 2050. Additionally, the company projects a near-term reduction of 18.52% in carbon emissions, targeting a decrease to approximately 305,010 kg CO2e by 2028. This commitment encompasses all scopes of emissions, reflecting a proactive approach to climate action. The emissions data is sourced directly from DiaSorin S.p.A., with no cascaded data from parent or related organizations. The company is actively working towards its climate goals, demonstrating a commitment to sustainability and environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142015201620172018201920202021202220232024
Scope 1
61,753,000
00,000,000
000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000
0,000,000
Scope 2
9,489.51
0,000.00
000,000
000,000
00,000,000
00,000,000
0,000,000
00,000,000
00,000,000
00,000
00,000,000
Scope 3
-
-
-
-
-
-
-
-
-
000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Diasorin's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Diasorin is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Diasorin is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

O-Link Corp.

JP
•
Health and social work services (85)
Updated 9 days ago

Genomic Health, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Immucor, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 8 days ago

Meridian Bioscience, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Bio Rad

US
•
Research and development services (73)
Updated about 19 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251028.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy